NTCOC
AMGN icon

Northern Trust Company of Connecticut’s Amgen AMGN Stock Holding History

Northern Trust Company of Connecticut’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		$35.4M Sell
310,353
-17,592
-5% -$2M 0.22% 90
2013
Q3 		$36.7M Sell
327,945
-81,170
-20% -$8.8M 0.24% 82
2013
Q2 		$40.4M Buy
+409,115
New +$42.5M 0.27% 66

Other funds holding AMGN

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Northern Trust Company of Connecticut's AMGN Position: Q4 2013 in Review

Northern Trust Company of Connecticut reduced its Amgen (AMGN) stake by 5.4% in Q4 2013, selling an estimated $2M and leaving 310,353 shares worth $35.4M. The position accounts for 0.22% of the portfolio, ranked #90.

Northern Trust Company of Connecticut first reported a position in AMGN in Q2 2013 and has held it in 3 quarters since. The position peaked at $40.4M in Q2 2013. 1,155 funds tracked by Wall St. Rank hold AMGN as of Q4 2013.

  • Northern Trust Company of Connecticut held 310,353 shares of Amgen worth $35.4M as of Q4 2013.
  • Northern Trust Company of Connecticut sold 17,592 Amgen shares in Q4 2013, an estimated $2M.
  • Amgen made up 0.22% of Northern Trust Company of Connecticut's portfolio in Q4 2013, its #90 holding.
  • Northern Trust Company of Connecticut first reported a position in Amgen in Q2 2013 and has held it in 3 quarters since.
  • Northern Trust Company of Connecticut's Amgen position peaked at $40.4M in Q2 2013.
  • 1,155 funds tracked by Wall St. Rank held Amgen as of Q4 2013.

Based on Northern Trust Company of Connecticut's 13F filing for Q4 2013, filed 12 Feb 2014.